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INTRODUCTION
Department of Internal Medicine, Lehigh Valley Health Network, Allentown, Pennsylvania
•  Hypomagnesemia is a well-known complication of proton pump inhibitor (PPI) use.1,2
•  Magnesium plays an important role in vascular endothelial regulation. Deficiency can 
lead to cerebral edema and posterior reversible encephalopathy (PRES).3
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CASE REPORT
•  A 42 year old male presented with anorexia, dyspepsia and nausea.
•  His medication list was notable for chronic PPI use. Physical exam at that time was 
normal. 
•  Initial laboratory findings were normal with the exception of a calcium of 7.5mg/dl.
•  He subsequently presented with a severe headache and dizziness. Laboratory studies 
revealed a calcium of 6.5 mg/dl, magnesium 0.4mg/dl and phosphorus of 3.8 mg/dl. 
A repeat calcium was 5.5 mg/dl. Urinary calcium was <5.0 mg/dl. Fractional urinary 
excretion of magnesium was 0.2%. A PTH level was normal. 
•  MRI of the brain showed bilateral cerebellar vasogenic edema. The differential diagnosis 
included posterior reversible encephalopathy syndrome (PRES) versus acute cerebellitis. 
EBV, Bartonella and Lyme serologies were negative. ANA testing was negative.
•  The PPI was discontinued. The magnesium level normalized with replacement and the 
calcium level rapidly normalized. His symptoms quickly resolved. 
•  A repeat MRI showed significant improvement in the cerebellar edema.
DISCUSSION
•  Hypomagnesemia can present with a variety of symptoms including seizures, cardiac 
arrhythmias, and neurological deficits.3
•  Magnesium is known to have a role in the regulation of vascular tone and reactivity.1 
•  Hypomagnesemia can cause endothelial dysfunction with capillary leakage, blood brain 
barrier disruption and axonal swelling leading to cerebral edema. 
•  Posterior reversible encephalopathy syndrome is due to disordered cerebral 
autoregulation and endothelial dysfunction.
•  Impaired active absorption of magnesium by intestinal epithelial cells is caused by 
PPI-induced inhibition of transient receptor potential melastatin TRPM6 and TRPM7 
channels.4
•  Hypomagnesemia also impairs release of PTH and decreases peripheral tissue 
sensitivity to PTH leading to a functional secondary hypoparathyroidism.5 
•  Our patient improved with magnesium repletion which is compatible with 
secondary hypoparathyroidism and reversible cerebellar findings due to PPI induced 
hypomagnesemia. 
